A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy
Clinical trial NCT02895529 · TERMINATED
Trial details
- NCT number
- NCT02895529
- Sponsor
- Xian-Janssen Pharmaceutical Ltd.
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-30
- Primary completion
- 2018-05-02
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.